David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
2501
DELISTED
First Foundation Inc
FFWM
| $913K | ﹤0.01% |
51,041
-7,897
| -13% | -$134K |
|
2502
Korn Ferry
KFY
$4.34B
| $913K | ﹤0.01% |
23,159
+14,273
| +161% | +$492K |
|
|
NPKI
2503
NPK International
NPKI
$1.12B
| $913K | ﹤0.01% |
91,279
-2,165
| -2% | -$17.7K |
|
|
WBK
2504
DELISTED
Westpac Banking Corporation
WBK
| $913K | ﹤0.01% |
36,194
+5,083
| +16% | +$128K |
|
2505
Qorvo
QRVO
$8.28B
| $912K | ﹤0.01% |
12,900
+5
| +0% | +$349 |
|
|
DERM
2506
DELISTED
Dermira, Inc.
DERM
| $912K | ﹤0.01% |
33,779
-988
| -3% | -$25.9K |
|
2507
HCI Group
HCI
$2.3B
| $911K | ﹤0.01% |
+23,825
| New | +$978K |
|
2508
CALL
New Oriental
EDU
$9.09B
| $909K | ﹤0.01% |
10,300
| – | – |
|
2509
Opko Health
OPK
$1.13B
| $909K | ﹤0.01% |
132,451
+71,198
| +116% | +$449K |
|
2510
Primoris Services
PRIM
$4.02B
| $909K | ﹤0.01% |
+30,912
| New | +$823K |
|
2511
PUT
Dollar General
DG
$27.2B
| $908K | ﹤0.01% |
11,200
| – | – |
|
|
GWR
2512
DELISTED
Genesee & Wyoming Inc.
GWR
| $907K | ﹤0.01% |
+12,261
| New | +$839K |
|
|
BOBE
2513
CALL
DELISTED
Bob Evans Farms, Inc.
BOBE
| $907K | ﹤0.01% |
11,700
| – | – |
|
2514
First Bancorp
FBNC
$2.65B
| $903K | ﹤0.01% |
26,238
+10,440
| +66% | +$327K |
|
2515
Kelly Services Class A
KELYA
$586M
| $900K | ﹤0.01% |
35,885
+15,995
| +80% | +$360K |
|
2516
Bright Horizons
BFAM
$3.59B
| $898K | ﹤0.01% |
10,411
-43,773
| -81% | -$3.49M |
|
2517
Trade Desk
TTD
$6.17B
| $898K | ﹤0.01% |
145,980
-2,852,430
| -95% | -$15.4M |
|
2518
Realty Income
O
$59.4B
| $897K | ﹤0.01% |
16,190
+8,241
| +104% | +$458K |
|
2519
Ryanair
RYAAY
$29.6B
| $897K | ﹤0.01% |
21,263
-17,645
| -45% | -$797K |
|
|
SHYF
2520
DELISTED
The Shyft Group
SHYF
| $897K | ﹤0.01% |
81,157
+48,218
| +146% | +$449K |
|
|
JUNO
2521
PUT
DELISTED
Juno Therapeutics, Inc.
JUNO
| $897K | ﹤0.01% |
20,000
| – | – |
|
|
GNMK
2522
DELISTED
GenMark Diagnostics, Inc
GNMK
| $896K | ﹤0.01% |
93,079
-161,303
| -63% | -$1.68M |
|
2523
CALL
NextEra Energy
NEE
$176B
| $894K | ﹤0.01% |
24,400
-68,800
| -74% | -$2.52M |
|
|
CBM
2524
DELISTED
Cambrex Corporation
CBM
| $893K | ﹤0.01% |
+16,228
| New | +$893K |
|
2525
Culp Inc
CULP
$44M
| $889K | ﹤0.01% |
27,157
+1,626
| +6% | +$49.1K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.